Healthcare -
Biotechnology - NASDAQ - US
$ 36.2
-0.958 %
$ 10.3 B
Market Cap
23.35
P/E
EXEL - TOTAL DEBT REPAID
Total Debt Repaid EXEL - Exelixis, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
14.87%
5 YEAR CAGR
7.18%
10 YEAR CAGR